Hhlr Advisors, Ltd. Axsome Therapeutics, Inc. Transaction History

Hhlr Advisors, Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $5.84 Million - $9.04 Million	100,000 New	100,000 $7.19 Million
Q3 2021 Nov 15, 2021	SELL	$19.91 - $68.26 $7.17 Million - $24.6 Million	-360,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$66.31 - $86.52 $23.9 Million - $31.1 Million	360,000 New	360,000 $29.3 Million

327

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.45B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.